Journal article
Daniel A. Wilkenfeld, Staci L. Orbell, Jennifer H. Lingler
Neurotherapeutics, vol. 18, 2021, pp. 673--685
Neurotherapeutics, vol. 18, 2021, pp. 673--685
View PDF
Cite
Cite
APA
Click to copy
Wilkenfeld, D. A., Orbell, S. L., & Lingler, J. H. (2021). Ethical {Considerations} in {Communicating} {Alzheimer}’s {Disease} {Neuroimaging} {Biomarker} {Test} {Results} to {Symptomatic} {Individuals}. Neurotherapeutics, 18, 673–685.
Chicago/Turabian
Click to copy
Wilkenfeld, Daniel A., Staci L. Orbell, and Jennifer H. Lingler. “Ethical {Considerations} in {Communicating} {Alzheimer}’s {Disease} {Neuroimaging} {Biomarker} {Test} {Results} to {Symptomatic} {Individuals}.” Neurotherapeutics 18 (2021): 673–685.
MLA
Click to copy
Wilkenfeld, Daniel A., et al. “Ethical {Considerations} in {Communicating} {Alzheimer}’s {Disease} {Neuroimaging} {Biomarker} {Test} {Results} to {Symptomatic} {Individuals}.” Neurotherapeutics, vol. 18, 2021, pp. 673–85.
BibTeX Click to copy
@article{wilkenfeld2021a,
title = {Ethical {Considerations} in {Communicating} {Alzheimer}’s {Disease} {Neuroimaging} {Biomarker} {Test} {Results} to {Symptomatic} {Individuals}},
year = {2021},
journal = {Neurotherapeutics},
pages = {673--685},
volume = {18},
author = {Wilkenfeld, Daniel A. and Orbell, Staci L. and Lingler, Jennifer H.}
}